-- Luye Pharma (HKG:2186) said it enrolled the first patient in a Phase 2 clinical trial in China for its investigational drug LY03017, according to a Wednesday Hong Kong bourse filing.
Shares of the pharma company fell over 2% in late-morning trade Thursday.
The drug is being tested for the treatment of psychosis associated with Alzheimer's disease.
McKesson (MCK) has an average rating of overweight and mean price target of $997.53, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $840.29, Change: $-1.96, Percent Change: -0.23%
Elbit Systems (ESLT) said Wednesday it was awarded several contracts totaling about $200 million by the Israel Ministry of Defense.The contracts, which were awarded during the joint military US-Israel military campaign against Iran, were for the delivery of advanced airborne munitions to the ministry, the company said.Price: $881.50, Change: $+16.02, Percent Change: +1.85%
Diamondback Energy (FANG) has an average rating of overweight and mean price target of $222.90, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $190.32, Change: $+0.51, Percent Change: +0.27%